These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 19509275)
1. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel. Goldblatt EM; Gentry ER; Fox MJ; Gryaznov SM; Shen C; Herbert BS Mol Cancer Ther; 2009 Jul; 8(7):2027-35. PubMed ID: 19509275 [TBL] [Abstract][Full Text] [Related]
2. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619 [TBL] [Abstract][Full Text] [Related]
3. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells. Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117 [TBL] [Abstract][Full Text] [Related]
4. Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer. Gellert GC; Dikmen ZG; Wright WE; Gryaznov S; Shay JW Breast Cancer Res Treat; 2006 Mar; 96(1):73-81. PubMed ID: 16319992 [TBL] [Abstract][Full Text] [Related]
5. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043 [TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent. Gryaznov SM; Jackson S; Dikmen G; Harley C; Herbert BS; Wright WE; Shay JW Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1577-9. PubMed ID: 18066830 [TBL] [Abstract][Full Text] [Related]
7. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts. Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709 [TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956 [TBL] [Abstract][Full Text] [Related]
11. Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab. Goldblatt EM; Erickson PA; Gentry ER; Gryaznov SM; Herbert BS Breast Cancer Res Treat; 2009 Nov; 118(1):21-32. PubMed ID: 18853252 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells. Sprouse AA; Herbert BS Anticancer Res; 2014 Oct; 34(10):5363-74. PubMed ID: 25275030 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo. Wang L; Wang C; Su B; Song Q; Zhang Y; Luo Y; Li Q; Tan W; Ma D; Wang L Biochem Cell Biol; 2013 Dec; 91(6):526-31. PubMed ID: 24219296 [TBL] [Abstract][Full Text] [Related]
15. Riccardin D, a macrocyclic bisbibenzy, inhibits human breast cancer growth through the suppression of telomerase activity. Sun CC; Xu HM; Yuan Y; Gao ZH; Lou HX; Qu XJ Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):488-98. PubMed ID: 24836118 [TBL] [Abstract][Full Text] [Related]
16. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer. Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263 [TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel. Lee HJ; Hanibuchi M; Kim SJ; Yu H; Kim MS; He J; Langley RR; Lehembre F; Regenass U; Fidler IJ Neuro Oncol; 2016 Apr; 18(4):486-96. PubMed ID: 26995790 [TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. Burchett KM; Yan Y; Ouellette MM PLoS One; 2014; 9(1):e85155. PubMed ID: 24409321 [TBL] [Abstract][Full Text] [Related]
19. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells]. Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888 [TBL] [Abstract][Full Text] [Related]
20. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells. Fawcett H; Mader JS; Robichaud M; Giacomantonio C; Hoskin DW Int J Oncol; 2005 Dec; 27(6):1717-26. PubMed ID: 16273228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]